Approve Suite
DemoCompaniesFDA recordsPricing
Sign inStart free

Terms of Service

Last updated: October 22, 2026

1. Acceptance of terms

By creating an account, subscribing to a plan, or otherwise using Approve Suite (the "Service"), a product of Catalyst Collective, LLC, a Delaware limited liability company doing business as Approve Suite("we," "us," "our"), you agree to these Terms of Service (the "Terms") and to our Privacy Policy, which is incorporated by reference. If you do not agree, do not use the Service. If you use the Service on behalf of a company or other organization, you confirm that you are authorized to accept these Terms for it, and "you" includes that organization.

2. The Service

Approve Suite is a regulatory monitoring and research tool for the life-science industry. It collects records that United States government agencies and public registries publish, currently including FDA warning letters, inspection classifications, recalls and enforcement reports, Federal Register documents, Title 21 of the Code of Federal Regulations, Drugs@FDA approvals and complete response letters, the FDA Purple Book, ClinicalTrials.gov and SEC EDGAR filings. It uses software and AI models to organize, label and summarize those records, builds company profiles from them, lets you ask questions about them ("Ask AI"), and delivers the items that match the watchlist you configure by dashboard, email digest and email alert.

The plans, their prices and what each includes are described on the pricing page at the time you sign up, and the limits each plan carries are set out in section 9. The sources we cover, and how often each is read, change as agencies change what and how they publish.

3. Not regulatory, legal, medical, or investment advice; accuracy of public records

Everything the Service shows you, including summaries, severity labels, "why it matters" notes, mappings from CFR sections to GxP areas or guidance documents, company profiles, pipeline and financial figures, and AI answers, is for informational purposes only. It is not regulatory, legal, quality, medical, or investment advice, and it does not replace your own regulatory intelligence process, your quality system, or qualified professionals. All compliance, filing, quality, investment and business decisions are your own responsibility.

The Service uses AI models (including third-party models from Anthropic) to classify and summarize public records. AI output is not perfect: items may be mislabeled, a severity may be wrong, a company may be matched incorrectly, a figure may be misread from a filing, and a relevant item may be missed or delayed. Source agencies also change, correct, delay, or withdraw what they publish. The Service is not a complete or real-time record of agency activity, and you must not rely on it as your only means of learning about a regulatory obligation. Always verify against the linked primary source. We make no representations or warranties regarding the accuracy, completeness, timeliness, or fitness for any particular purpose of any item, summary, profile, answer, or alert.

The Service is not affiliated with, endorsed by, or operated on behalf of the U.S. Food and Drug Administration, the Securities and Exchange Commission, the National Library of Medicine, or any other agency.

4. AI features

Ask AI and the other AI features of the Service are generated by large language models provided by Anthropic. When you ask a question, the text you type, any text you highlighted, the page and filters you were viewing, and the results of the database lookups the model runs to answer you are sent to Anthropic to produce the answer. Conversations are stored on our servers so you can return to them; you can rename or delete a conversation at any time, and deleting your account deletes all of them.

AI answers can be wrong, incomplete or out of date, may miscount or misattribute records, and are subject to section 3 in full. Verify anything you rely on against the cited source. AI use is capped as set out in section 9, and questions that are not about the life-science industry or the data in the Service may be declined. We may change the models behind these features, their limits, and how they behave at any time.

Do not submit personal data about other people, patient or health data, unpublished regulatory submissions, trade secrets, or other confidential information through AI features, and do not use them to generate content that is unlawful, harmful or infringing, or to attempt to extract our prompts or the configuration of the models. We do not use your questions to train AI models, and under our agreement with our provider it does not use them for training either. We may review a conversation to investigate abuse, a security incident, or a support request you make.

5. Eligibility and accounts

The Service is a professional tool for use in a business. You must be at least 18 years old to create an account. You must provide accurate information when creating your account and keep it current. One account is for one person: you may not share credentials, and each person who uses the Service needs their own account. If you sign in with Google, Google's terms also apply to that sign-in. You are responsible for maintaining the confidentiality of your credentials and for all activity under your account. Notify us immediately at info@approvesuite.com of any unauthorized access.

If your plan includes more than one seat, the person who purchases it is responsible for everyone they add, for those people's compliance with these Terms, and for removing them when they leave.

6. Acceptable use

You agree not to:

  • Use the Service for any unlawful purpose, or in violation of any applicable law or regulation
  • Attempt to reverse-engineer, scrape, crawl, or bulk-extract the Service's data, classifications, summaries, company profiles, AI prompts, or AI outputs, or use them to build or train a competing product or dataset
  • Resell, republish, or redistribute digests, alerts, profiles, AI answers, or our summaries outside your own organization without written permission (forwarding an individual item to a colleague is fine)
  • Share one account among several people, or otherwise circumvent plan limits, AI limits, rate limits, or usage caps through account sharing, multiple free accounts, coordinated requests, IP rotation, or any other technical means
  • Add delivery addresses for people who have not agreed to receive the emails, or use the Service to send unsolicited messages in violation of anti-spam laws (including CAN-SPAM)
  • Automate requests to the Service at a rate that exceeds normal human usage, except through an interface we document for that purpose
  • Upload or submit content that is unlawful, infringing, defamatory, or contains malicious code, or misrepresent who you are or who you work for
  • Interfere with the Service's infrastructure or security, or probe, scan, or test it for vulnerabilities without our written permission

7. Free plan and the weekly newsletter

The free plan is described on the pricing page at the time of sign-up and is limited to one per person. We may modify, limit, or discontinue the free plan, or what it includes (such as the number of AI questions), at any time. Free-plan accounts receive a weekly email summarizing the week's regulatory events; you can turn it off from the unsubscribe link in any issue.

Our public weekly newsletter is free and separate from an account. Subscribing requires confirming your address by email, every issue carries an unsubscribe link, and we may stop publishing it at any time.

8. Paid plans, billing, and cancellation

Paid plans are billed in advance, monthly or annually, on a recurring basis. Payments are processed by Stripe; by subscribing you authorize us and Stripe to charge your payment method at the start of each billing period. Subscriptions automatically renew at the end of each billing period at the then-current price for your plan unless you cancel before the renewal date.

You may cancel at any time from your profile settings. Cancellation takes effect at the end of the current billing period and you keep access through that date. Fees are non-refundable and we do not offer refunds or credits for partial months or years, downgrades, or unused features, except where the law requires otherwise. If you believe you were charged in error, contact us at info@approvesuite.com before disputing the charge with your bank; we may suspend an account while a chargeback is open.

Prices exclude taxes. If we are required to collect sales, use, value-added, or similar taxes on your subscription, they will be added to your invoice. If a payment fails, we may retry it, and if it remains unpaid we may suspend paid features or move your account to the free plan, which does not include watchlists, digests, or alerts. We may change pricing with 30 days' notice by email or in-app notice; the new price applies from your next renewal after the notice period. We may offer promotions or pause new subscriptions at our discretion.

9. Plan limits, fair use, and rate limiting

Each plan includes limits: how far back the archive goes, how many watchlists you can create, how many seats you have, and how many AI questions you can ask. The plans currently include:

  • Free ($0, no payment card): records from every live source for the last 7 days, with feed filters and analytics over those days; the company explorer and company profiles; an Ask AI trial of 3 questions in total for the account; and the weekly industry top-5 email. The free plan does not include a watchlist, the daily digest or email alerts. 1 seat.
  • Pro ($79 a month or $790 a year): everything in Free, plus 1 watchlist of companies, indications, CFR parts, GxP areas and keywords; a daily email digest at the hour you choose; instant email alerts on critical events that match your watchlist; the full archive, charts and saved views; full Ask AI, up to 40 questions a day, counted per calendar day in UTC; and each CFR change mapped to its GxP area and the guidances that cite it. 1 seat.

To protect the Service for all users, we apply automatic rate limiting; requests that exceed these limits receive a 429 Too Many Requests response and may be retried after a short delay. We may throttle, restrict, or suspend accounts that abuse the Service, generate unreasonable load, or attempt to circumvent its limits.

API and MCP access. An API key is issued to an account and is that account's responsibility: keep it secret, do not share it, and revoke it if it leaks. Each plan includes a number of API requests per month and per minute (stated on the developers page); requests past those limits receive 402 or 429 responses. Automated access to the Service other than through the API with a valid key is not permitted.

10. Your content, confidentiality, and feedback

You retain ownership of what you enter into the Service: your watchlists and rules, saved views, delivery settings, Ask AI questions, and any feedback you send. You grant us a non-exclusive, worldwide license to host, process, and display that content solely to provide, secure, and improve the Service for you. We treat the contents of your watchlist and your Ask AI conversations as confidential, because they can reveal what your company is working on: we do not disclose them to other customers, do not sell them, and do not use them to train AI models. To match the companies you name against trial sponsors, the names you type may be sent to ClinicalTrials.gov's public search interface; nothing that identifies you or your account travels with them.

If you add other people as digest recipients, you confirm that they have agreed to receive those emails. We send each new address a verification email and deliver to it only after the recipient confirms; every digest carries an unsubscribe link that the recipient can use without your involvement.

If you send us suggestions, ideas, or other feedback about the Service, you grant us a perpetual, irrevocable, royalty-free license to use it for any purpose without obligation to you. We may also collect and use data about how the Service is used in aggregated or de-identified form, which does not identify you or your organization, to operate, improve, and promote the Service.

11. Intellectual property, source material, and third-party sites

The underlying government records belong to the public domain or to their respective publishers, and we claim no ownership of them. The Service itself, including its design, code, taxonomy, classifications, summaries, mappings, company profiles, and branding, is owned by Catalyst Collective, LLC and protected by applicable intellectual property laws. Subject to these Terms, we grant you a limited, non-exclusive, non-transferable, revocable license to use the Service for your internal business purposes. Nothing in these Terms grants you a right to use our trademarks, including the Approve Suite name, or our proprietary technology.

Data licence (API). Data you receive through the API may be used in your own products, systems and analyses, and shown to your own users with the source and Approve Suite named. You may not re-serve the dataset as such (as a download, a feed, an API or a bulk dataset), build a competing dataset from it, or use our summaries, classifications and company links to train or fine-tune a model, without a written agreement. The public records themselves remain public; this licence covers what we add to them.

The Service links to agency websites, registries, and other third-party sites, and may embed content such as a product tour video hosted by a third party. We do not control those sites, are not responsible for their content or availability, and your use of them is governed by their own terms. If you believe content in the Service infringes your copyright, write to info@approvesuite.com with the details and we will respond promptly.

12. Electronic communications and notices

By creating an account you agree to receive emails from us about your account, security, billing, and changes to the Service or these Terms, and the digests and alerts you configure. These are part of the Service and you cannot opt out of them while you keep an account, other than by changing your delivery settings. We send product updates, tips, and offers only if you asked for them, and every such email has a one-click unsubscribe. You agree that notices we send to the email address on your account, or post in the Service, satisfy any legal requirement that a notice be in writing. Notices to us go to info@approvesuite.com.

13. Changes to the Service

We improve the Service continuously and may add, change, or remove features, sources, models, and limits at any time. Where a change materially reduces what a paid plan includes, we will give you reasonable notice where practicable, and you may cancel under section 8. We may also suspend the Service for maintenance or to protect its security, and we will try to do so outside business hours in the United States. We are not liable to you for any modification, suspension, or discontinuation of the Service or any part of it.

14. Disclaimer of warranties

THE SERVICE IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. WE DO NOT WARRANT THAT THE SERVICE WILL BE ERROR-FREE, COMPLETE, TIMELY, SECURE, OR UNINTERRUPTED, THAT ANY ALERT WILL BE DELIVERED, THAT ANY AI ANSWER OR CLASSIFICATION WILL BE CORRECT, OR THAT THE SERVICE WILL MEET YOUR REQUIREMENTS OR ANY REGULATORY OBLIGATION. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO SOME OF THE ABOVE MAY NOT APPLY TO YOU.

15. Limitation of liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, CATALYST COLLECTIVE, LLC (D/B/A APPROVE SUITE) AND ITS MEMBERS, MANAGERS, OFFICERS, EMPLOYEES, AGENTS, AND SUPPLIERS SHALL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, OR ANY LOSS OF PROFITS, REVENUES, DATA, GOODWILL, OR BUSINESS OPPORTUNITY, WHETHER INCURRED DIRECTLY OR INDIRECTLY, INCLUDING ANY REGULATORY ACTION, MISSED DEADLINE, COMPLIANCE FAILURE, OR DECISION MADE IN RELIANCE ON THE SERVICE, ARISING OUT OF YOUR USE OF OR INABILITY TO USE THE SERVICE OR ANY ITEM IT DID OR DID NOT DELIVER, EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. OUR TOTAL LIABILITY FOR ALL CLAIMS ARISING FROM OR RELATING TO THESE TERMS OR THE SERVICE SHALL NOT EXCEED THE GREATER OF THE AMOUNT YOU PAID US IN THE 12 MONTHS PRECEDING THE CLAIM AND ONE HUNDRED U.S. DOLLARS (US$100). THESE LIMITATIONS APPLY TO ALL THEORIES OF LIABILITY AND ARE A FUNDAMENTAL BASIS OF THE BARGAIN BETWEEN US. SOME JURISDICTIONS DO NOT ALLOW THE LIMITATION OF CERTAIN DAMAGES, SO SOME OF THE ABOVE MAY NOT APPLY TO YOU.

16. Indemnification

You agree to indemnify, defend, and hold harmless Catalyst Collective, LLC and its members, managers, officers, employees, and agents from and against any claims, liabilities, damages, losses, and expenses (including reasonable legal fees) arising out of or in any way connected with: (a) your access to or use of the Service; (b) your violation of these Terms; (c) any content you submit through the Service, including Ask AI questions and delivery addresses you add; or (d) your violation of any third-party right, including intellectual property or privacy rights.

17. Term and termination

These Terms apply from the moment you first use the Service until your account is closed. You may delete your account at any time from your profile settings; doing so cancels any subscription and removes your watchlists, conversations, and personal data as described in the Privacy Policy. We may suspend or terminate your account, with or without prior notice, if you violate these Terms, fail to pay, or if we are required to by law, and we may close a free account that has been inactive for more than 12 months after notifying the address on the account. Upon termination, your right to use the Service ends, and your watchlists and personal data will be deleted within 30 days except where we must retain them by law. Sections 3, 4, 10, 11, 14, 15, 16, 17, 19, 20, and 22 survive termination.

18. Force majeure

We are not liable for any failure or delay in performance resulting from causes beyond our reasonable control, including natural disasters, acts of government, government shutdowns or agency website and API outages, changes in what agencies publish, labor disputes, internet or infrastructure outages, or failures of third-party service providers.

19. Governing law and disputes

These Terms are governed by the laws of the State of Delaware and the federal laws of the United States, without regard to conflict of law provisions. Before initiating formal legal proceedings, you agree to contact us at info@approvesuite.com and give us 30 days to attempt to resolve the dispute informally. Any dispute that is not resolved informally shall be brought exclusively in the state or federal courts located in Delaware, and you consent to personal jurisdiction and venue there, except that either party may seek injunctive relief in any court of competent jurisdiction to protect its intellectual property or confidential information.

Jury and class action waiver. To the fullest extent permitted by law, you and we each waive the right to a jury trial, and agree that disputes will be brought only in an individual capacity and not as a plaintiff or class member in any purported class, collective, or representative proceeding. Time limit. Any claim arising out of these Terms or the Service must be filed within one year after it arose, or it is permanently barred. Nothing in this section limits rights that the law of your place of residence grants you and does not permit you to waive.

20. Export controls and sanctions

You may not use the Service if you are located in, or are a national or resident of, a country or region subject to comprehensive United States sanctions, or if you are on any U.S. government list of prohibited or restricted parties. You agree to comply with all applicable export control and sanctions laws in your use of the Service.

21. Changes to these terms

We may update these Terms from time to time. We will notify you of material changes by email or in-app notice at least 14 days before the changes take effect, and will update the "Last updated" date at the top of this page. Continued use of the Service after changes take effect constitutes acceptance of the updated Terms; if you do not agree, close your account before that date.

22. General

Entire agreement. These Terms, together with our Privacy Policy and any plan description or order you accept, constitute the entire agreement between you and Catalyst Collective, LLC regarding the Service and supersede all prior agreements and understandings.

Severability. If any provision of these Terms is found to be unenforceable, that provision will be modified to the minimum extent necessary to make it enforceable, and the remaining provisions will continue in full force.

No waiver. Our failure to enforce any right or provision of these Terms will not be considered a waiver of that right or provision.

Assignment. You may not assign your rights or obligations under these Terms without our prior written consent. We may assign these Terms without restriction, including to an affiliate or in connection with a merger, acquisition, or sale of assets.

Relationship. We are independent contractors. These Terms create no partnership, joint venture, agency, or employment relationship, and there are no third-party beneficiaries. Headings are for convenience only.

23. Corrections, and companies and people named in public records

The Service reports what government agencies and public registries have published about companies and, in some records, about named individuals. We did not create those records, we do not decide what they say, and we cannot change them at the source.

If you believe the Service attaches a record to the wrong company or person, states something the source does not say, or shows a record the agency has since corrected, closed out or withdrawn, write to info@approvesuite.com with the address of the page or item and what is wrong. You do not need an account. We check every such report against the primary source and promptly correct or remove whatever does not match it. We do not remove an accurate report of a public record on request; a request to change the record itself goes to the agency that published it.

24. Contact

Questions about these Terms? Contact us at info@approvesuite.com (approvesuite.com), or by mail at Catalyst Collective, LLC, c/o Legalinc Corporate Services Inc., 131 Continental Dr, Suite 305, Newark, DE 19713, United States.

DemoCompaniesFDA recordsFree toolsPricingFAQWeeklyAPI

Approve Suite Weekly

This week in FDA, every Tuesday. Free.

One email a week. Unsubscribe any time.

TermsPrivacyYour privacy choicesApprove Suite © 2026